诺诚健华-U
(688428)
| 流通市值：46.97亿 | | | 总市值：310.92亿 |
| 流通股本：2.66亿 | | | 总股本：17.63亿 |
| 报告期 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 1,009,448,013.44 | 697,748,228.93 | 419,737,910.92 | 165,824,020.34 |
| 营业收入 | 1,009,448,013.44 | 697,748,228.93 | 419,737,910.92 | 165,824,020.34 |
| 二、营业总成本 | 1,463,013,205.36 | 975,965,605.67 | 679,410,003.05 | 303,015,436.11 |
| 营业成本 | 138,441,152.27 | 98,028,598.02 | 60,139,759.03 | 24,290,417.68 |
| 税金及附加 | 15,235,964.22 | 10,737,102.16 | 6,641,312.43 | 3,036,877.51 |
| 销售费用 | 419,960,584.26 | 273,927,859.06 | 157,153,114.33 | 89,533,244.9 |
| 管理费用 | 168,528,403.9 | 125,820,073.29 | 84,975,021.7 | 42,408,649.62 |
| 研发费用 | 814,609,352.61 | 614,983,375.71 | 421,404,233.69 | 177,728,720.87 |
| 财务费用 | -93,762,251.9 | -147,531,402.57 | -50,903,438.13 | -33,982,474.47 |
| 其中:利息费用 | 33,794,672.67 | 20,557,333.16 | 10,471,937.88 | 5,177,359.39 |
| 其中:利息收入 | 171,589,406.1 | 138,559,308.84 | 94,559,141.39 | 47,128,560.55 |
| 加:公允价值变动收益 | -30,462,084.77 | -29,423,716.12 | -23,256,781.3 | -16,476,486.81 |
| 加:投资收益 | 7,116,535.18 | 3,091,034.65 | -932,689.31 | -1,339,525.49 |
| 资产减值损失(新) | -104,960.97 | - | - | - |
| 信用减值损失(新) | -1,495,049.39 | -683,961.47 | -668,422.46 | - |
| 其他收益 | 27,461,588.87 | 19,951,442.33 | 16,614,129.5 | 9,316,072.39 |
| 营业利润平衡项目 | 0 | 0 | 0 | 0 |
| 四、营业利润 | -451,049,163 | -285,282,577.35 | -267,915,855.7 | -145,691,355.68 |
| 加:营业外收入 | 274,521.12 | 47,821.12 | 46,721.12 | 31,000.1 |
| 减:营业外支出 | 1,818,276.13 | 54,408.11 | 54,343.66 | - |
| 利润总额平衡项目 | 0 | 0 | 0 | 0 |
| 五、利润总额 | -452,592,918.01 | -285,289,164.34 | -267,923,478.24 | -145,660,355.58 |
| 减:所得税费用 | 262,747.31 | 28,419.7 | 28,449.7 | 20.1 |
| 六、净利润 | -452,855,665.32 | -285,317,584.04 | -267,951,927.94 | -145,660,375.68 |
| 持续经营净利润 | -452,855,665.32 | -285,317,584.04 | -267,951,927.94 | -145,660,375.68 |
| 归属于母公司股东的净利润 | -440,632,966.49 | -275,409,931.99 | -261,840,060.1 | -142,403,395.72 |
| 少数股东损益 | -12,222,698.83 | -9,907,652.05 | -6,111,867.84 | -3,256,979.96 |
| (一)基本每股收益 | -0.26 | -0.16 | -0.16 | -0.08 |
| (二)稀释每股收益 | -0.26 | -0.16 | -0.16 | -0.08 |
| 八、其他综合收益 | 60,761,064.42 | -61,320,760.95 | 36,330,518.75 | 10,452,098.53 |
| 归属于母公司股东的其他综合收益 | 60,761,064.42 | -61,320,760.95 | 36,330,518.75 | 10,452,098.53 |
| 九、综合收益总额 | -392,094,600.9 | -346,638,344.99 | -231,621,409.19 | -135,208,277.15 |
| 归属于母公司股东的综合收益总额 | -379,871,902.07 | -336,730,692.94 | -225,509,541.35 | -131,951,297.19 |
| 归属于少数股东的综合收益总额 | -12,222,698.83 | -9,907,652.05 | -6,111,867.84 | -3,256,979.96 |
| 公告日期 | 2025-03-28 | 2024-11-12 | 2024-08-21 | 2024-05-14 |
| 审计意见(境内) | 标准无保留意见 | | | |